AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Researchers have applied VIP/NTM-reactive natural antibodies to HIV infection therapy.
"In sera of HIV-infected individuals natural antibodies recognizing nonimmunogenic C-terminal domain of the second conserved region of HIV-1 gp120 and the vasoactive intestinal peptide (VIP) were identified. It has been demonstrated that these antibodies are significantly more prevalent in asymptomatic carriers than in AIDS patients and that their titer strongly correlates with disease progression," scientists in Yugoslavia report.
"These findings point out the VIP/C2-reactive natural antibodies as an important agent for immunotherapy of HIV disease," wrote Veljko Veljkovic at the Institute of Nuclear Sciences in Yugoslavia and R. Metlas at Diapharm Ltd. in the U.K.
Veljkovic and Metlas published their study in International Reviews ...